Tuesday, November 3, 2020

Chart of the Day - Immunovant - All Time High


Find trading opportunities using many of Barchart.com’s free tools, such as Trading Signals, Screeners, and Barchart Opinions.
Barchart.com's Chart of the Day - Immunovant - All Time High
November 3, 2020: Published by Barchart.com

The Barchart Chart of the Day belongs to the biomedical company Immunovant (NASDAQ:IMVT).  I found the stock by sorting Barchart's New All-Time High list first by the highest Weighted Alpha, then used the Flipchart function to review the charts for consistent price appreciation.  Since the Trend Spotter signaled a buy on 10/1 the stock gained 19.32%.

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. 

IMVT Immunovant

 

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart technical indicators:

  • 100% technical buy signal
  • 296.10+ Weighted Alpha
  • 341.93% gain in the last year
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 9 new highs and up 23.49% in the last month
  • Relative Strength Index 66.52%
  • Technical support level at 43.52
  • Recently traded at 44.90 with a 50 day moving average of 38.59

Fundamental factors:

  • Market Cap $ 3.92 billion
  • Although Wall Street analysts issued 9 strong buy and 1 buy recommendation they have not released their Revenue, Earnings and Price projections
  • Only 530 investors are monitoring the stock on Seeking Alpha

The #1 strategy that could have sent you 20 years with no losing years…
Trophy Trades have already proven to have the potential to earn you as much as $13.5 million dollars…
But it’s never been released to the public before - now that changes for you
Click here to save your spot for the LIVE reveal of Trophy Trades
(By clicking the link above you will automatically opt-in to receive emails from WealthPress)

More on this symbol:
         
You're receiving this email because you registered for the Barchart's Chart of the Day subscription service/newsletter or because you have a prior existing relationship with Barchart.com and previously provided your email address to us. To ensure that you continue to receive emails from us, add newsletters@barchart.com to your address book today.

Copyright © 2018, All rights reserved. The information contained herein is derived from public sources believed to be reliable but is not guaranteed as to its accuracy or completeness. No responsibility is assumed for the use of this material and no express or implied warranties nor guarantees are made. Nothing contained herein should be construed as an offer to buy or sell, or as a solicitation to buy or sell, any securities or derivative instruments.
 

Barchart.com, Inc. • 209 W Jackson • Chicago, IL 60606 • USA
Unsubscribe from this list

No comments:

Post a Comment

PayPal, Tesla, SpaceX... Elon's Next Project Is Bigger Than Them All

Musk's "silent partner" could soar as a result of his new AI project ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ...